Bellco was a pioneer in haemodialysis, they were acquired by Medtronic in 2016.
Human
We invest in the trailblazers redefining how people stay healthy, live longer, and thrive
Backing the future of Medicine, Wellness, and Population Health
Our Human investment focus is centred on transformative technologies that improve lives. From AI in diagnostics to breakthroughs in personalised medicine, we invest in early-stage healthtech, medtech, and biotech startups pushing the boundaries of what’s possible.
We’re drawn to founders who combine scientific rigour with scalable ambition—those building platforms and tools that can address healthcare challenges across entire populations.
Whether it’s improving detection, treatment, or access, the trailblazers we back are shaping the future of digital health, remote monitoring, and next-generation therapeutics.
Meet the team behind our Medtech, Health, and Bio investments
/
Investing in startups improving healthcare outcomes
/
-
HumanBellco
-
HumanCharco Neurotech’s CUE1 wearable delivers individualised vibrotactile neuromodulation that helps thousands of people with Parkinson’s move more freely and live better, without surgery or drugs.
Charco Neurotech
-
HumanCiphergen Biosystems developed a patented protein chip to detect proteins within biological samples. The company successfully floated on NASDAQ.
Ciphergen Biosystems
-
Human PlanetConstructive Bio is a synthetic biology company that rewrites genomes to create novel biomolecules, enabling next-generation materials and therapeutics beyond the limits of natural biology.
Constructive Bio
-
HumanDoctify is a healthtech platform providing SaaS tools and booking services that connect patients with private healthcare providers, making access to care faster, simpler, and more transparent.
Doctify
-
HumanHealx is a Cambridge-based biotech using generative AI to accelerate drug discovery and develop treatments for rare diseases that currently lack approved therapies.
Healx
-
HumanIgenomix is a reproductive genetics company providing advanced diagnostic testing to improve fertility outcomes and support women’s health globally. It was acquired by EQT in 2019.
Igenomix
-
HumanNatrox® is an advanced wound care therapy developed in Cambridge that delivers continuous topical oxygen to accelerate healing in acute and chronic wounds.
Natrox
-
HumanNuclera is a biotech company making proteins more accessible through its benchtop eProtein Discovery™ system, combining cell-free synthesis and digital microfluidics for rapid, automated protein production.
Nuclera
-
HumanOptos was a medtech company whose Optomap imaging technology enabled early detection of retinal diseases through non-invasive, wide-field digital scans. It listed on the London Stock Exchange in 2006 and was acquired by Nikon for $400m in 2015.
Optos
-
HumanOrganOx is a medtech company pioneering normothermic liver perfusion with its metra device, improving transplant outcomes and increasing the use of donor organs worldwide.
OrganOx
-
HumanOri Biotech is a cell and gene therapy manufacturing company whose IRO® platform automates and accelerates production to make advanced therapies more scalable, affordable, and accessible.
Ori Biotech
-
HumanOxford Nanopore Technologies develops scalable, real-time DNA/RNA sequencing tools that enable fast, accessible analysis across research, healthcare, and global diagnostics.
Oxford Nanopore Technologies
-
HumanPhoreMost is a biotech company expanding the potential of targeted protein degradation through novel mini-protein engineering and proprietary platforms to develop next-generation degrader therapies.
PhoreMost
-
HumanQuibim is a medtech company turning imaging data into predictive insights to drive precision medicine in oncology, neurology, and immunology.
Quibim
-
HumanSolexa developed next-generation genome sequencing technology to make high-speed, low-cost DNA analysis accessible for research and clinical diagnostics. It was acquired by Illumina in 2007.
Solexa
